mTORC2 regulates hedgehog pathway activity by promoting stability to Gli2 protein and its nuclear translocation

Samarpan Maiti1, Susmita Mondal1, Eswara M Satyavarapu1

  • 1Cancer Biology and Inflammatory Disorder Division, Council of Scientific and Industrial Research (CSIR)-Indian Institute of Chemical Biology, 4, Raja S.C. Mullick Road, Jadavpur, Kolkata 700032, India.

Cell Death & Disease
|July 14, 2017
PubMed

Insights

Mammalian target of rapamycin complex 2 (mTORC2) signaling enhances the hedgehog pathway, promoting glioblastoma growth, metastasis, and cancer stem cell regeneration. Inhibiting mTORC2 reduces these effects, suggesting mTORC2 as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Aberrant activation of mammalian target of rapamycin complex 2 (mTORC2) is implicated in cancer, making it a key therapeutic target.
  • The hedgehog signaling pathway is frequently hyperactivated in cancer, regulating genes involved in angiogenesis, metastasis, proliferation, and cancer stem cell (CSC) regeneration.

Purpose of the Study:

  • To investigate the molecular crosstalk between mTORC2 and the hedgehog pathway in glioblastoma multiforme.
  • To determine the role of mTORC2 in regulating hedgehog pathway activity and its downstream effects on cancer progression and CSCs.

Main Methods:

  • Utilized glioblastoma multiforme as a model system to study the interaction between mTORC2 and the hedgehog pathway.
  • Assessed the expression of hedgehog pathway molecules (Gli1, Gli2, Ptch1) and target genes (Cyclin D1/D2/E, Snail, Slug, VEGF) at mRNA and protein levels.
  • Investigated the effect of mTORC2 inhibition on hedgehog pathway activity, cancer cell proliferation, metastasis, angiogenesis, and CSC regeneration, including Gli2 ubiquitination and GSK3β activity.

Main Results:

  • Elevated mTORC2 activity increased the expression of hedgehog pathway components and amplified its target genes, correlating with enhanced metastasis, angiogenesis, proliferation, and CSC regeneration.
  • Inhibition of mTORC2 decreased hedgehog pathway activity and attenuated these cancer-promoting events, indicating a significant crosstalk.
  • mTORC2 was found to inhibit Gli2 ubiquitination by inactivating GSK3β, thereby promoting Gli2 stability and nuclear translocation, leading to increased clonogenic properties and CD133+ cells.

Conclusions:

  • Elevated mTORC2 activity drives angiogenesis, metastasis, cellular proliferation, and CSC regeneration through the hedgehog pathway in glioblastoma.
  • mTORC2 inhibition effectively reduces hedgehog pathway proteins and CSCs, highlighting its therapeutic potential.
  • These findings provide a strong rationale for incorporating mTORC2 inhibitors into therapeutic regimens for targeting CSCs in glioblastoma.

Related Concept Videos

Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
10.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K
GTPases and their Regulation02:14

GTPases and their Regulation

3.1K
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
10.1K